What changed
Insmed appointed Paul Hudson and Utpal Koppikar as independent directors, effective immediately. Hudson served as CEO of Sanofi from September 2019 through February 2026 and was CEO of Novartis Pharmaceuticals from 2016 to 2019. Koppikar has been CFO of Verily Health since April 2023 and was EVP and CFO of Atara Biotherapeutics from 2018 to 2023. The additions bring global commercial and financial expertise to the board as Insmed advances its pipeline and global growth strategy.
Why it matters
Insmed appointed Paul Hudson and Utpal Koppikar as independent directors, effective immediately. Hudson served as CEO of Sanofi from September 2019 through February 2026 and was CEO of Novartis Pharma
← Dashboard
Oct 20, 2026 08:05 PM ET